Generation of High-Quality Antibodies/Peptides with High Diversity Over 1 billion proprietary biopharmaceutical data, obtained from our lab. Our proprietary method and AI technology enable us to identify hidden valuable antibodies/peptides by predicting fundamental properties of biopharmaceuticals, e.g. affinity, specificity, phage growth bias in E. coli, immunogenicity, etc.